1. Home
  2. LGL vs BSEM Comparison

LGL vs BSEM Comparison

Compare LGL & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGL Group Inc. (The)

LGL

LGL Group Inc. (The)

HOLD

Current Price

$6.85

Market Cap

93.0M

Sector

Technology

ML Signal

HOLD

Logo BioStem Technologies Inc. Common Stock

BSEM

BioStem Technologies Inc. Common Stock

N/A

Current Price

$3.71

Market Cap

76.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LGL
BSEM
Founded
1917
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.0M
76.9M
IPO Year
2017
2026

Fundamental Metrics

Financial Performance
Metric
LGL
BSEM
Price
$6.85
$3.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.0K
★ 136.7K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 37.50
N/A
EPS
★ N/A
N/A
Revenue
★ $4,169,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.45
$2.25
52 Week High
$7.88
$5.44

Technical Indicators

Market Signals
Indicator
LGL
BSEM
Relative Strength Index (RSI) 43.59 49.99
Support Level $6.63 $3.69
Resistance Level $7.34 $4.65
Average True Range (ATR) 0.24 0.46
MACD -0.02 -0.02
Stochastic Oscillator 39.96 17.56

Price Performance

Historical Comparison
LGL
BSEM

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment, and manufacturing business activities. The company has two reportable segments: Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications, including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About BSEM BioStem Technologies Inc. Common Stock

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Share on Social Networks: